Healthcare Transactions and Compliance


Published on

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide
  • Unprecedented Levels of Change PPACA – on-going publication of implementing regulations – ever evolving regulatory landscapeMajor Goal = promote and reward lower cost, higher quality care and greater accountability across providers for patient healthCare Delivery Reform - ACOsPayment Reform – FFS to bundled and global payments, comparative effectivenessIncreased Enforcement – HEAT Task ForceBottom Line = Providers must lower costs and increase valueSome providers struggle with the requirements necessary to effectively provide services and to participate in the next generation of health care delivery – e.g. the expense associated with EHR acquisition and implementation.This motivates them to sell to or affiliate with larger and stronger players in the market.Other providers are well positioned to effectively compete in the new landscape.As a result, they may seek out acquisitions, partnerships, or collaborations that will expand their footprint, establish them as an industry leader in a particular area or improve economies of scale.
  • Deal activity in 2011 was up 11% from the $205.6 billion worth of deals in 2010. Hospital and health system consolidation trend continues.Hospitals are facing payment challenges and spiraling health care costs – Consolidation allows them to increase market share and negotiate leverage with commercial payors.Ability to demonstrate lower costs while providing high quality care will be the key driver in governmental and commercial reimbursement going forward. Physician alignment is another strategy for hospitals to control costs, drive improved quality and offer continuity of care. At the same time physicians are preparing for a future where they will be required to provide care for more patients with less reimbursement and opt to give up their independence for the income stability afforded by hospital employment.Have seen the expansion of insurance companies into health care services. Since passage of ACA there have been several mergers, acquisitions and partnerships of insurers and provider systems with the goal of reducing health care costs and improving quality. E.g. proposed affiliation between Highmark and West Penn Allegheny Health System, Humana's acquisition of Concentra (which provides PT, urgent care and OT), and WellPoint's acquisition of CareMore Health Plan (an MA Plan and Clinic Network).Payor and provider affiliations will become more common as ACA is implemented and demand for lost-cost, high quality care escalates.Urgent care centers are gateway to the hospital (alternative to crowded ED) and competition from pharmacy clinics – CVS and Walgreens
  • This is just a sample of the general categories of laws. There may be additional laws or regulatory requirements to consider depending on the industry in which the target participates and the review will have to be targeted to the industries specific regulatory issues – e.g. health plans, pharmacies, pharma manufacturer, medical device manufacturer, physician, laboratory, hospital, nursing homes, home health.Maybe specific state or federal regulatory schemes applicable to the industry – e.g., state gift ban, sunshine laws, etc.I'm going to discuss in a little more depth some of these laws that have take on greater and greater importance in the deals I work on.
  • Federal and State fraud and abuse laws are always a main/significant focus of any regulatory review in health care transactions.These laws are not only important in the due diligence stage of a transaction but are an important consideration from the outset when the deal is being structured. Health care transactions must be carefully structured so as not to run afoul of federal and state fraud and abuse lawsFraud and abuse laws will often determine permissible deal structures – for example if a client comes to me and says we'd like to enter into a JV with a physician group to own and operate a lab. I have to tell them this is not permissible under the Stark Law if the physicians will refer patients to the lab.The AKS and Stark Law contain safe harbors and exceptions for permissible arrangements and transactions should be structured to comply with these whenever possible – e.g. JVs should comply with the small investment interest safe harbor to the AKS, if there are ancillary arrangements as part of the transaction such as consulting agreements, equipment leases or real estate arrangements – these should all be structured to comply with applicable safe harbors.FMV is a key component under the AKS and Stark Law. Buyers in the health care industry face enforcement risk if they overvalue a target, disguise payments. Parties need to be able to document FMV and how it was determined. Fraud and abuse laws may limit the payment structures available to the parties. We'll discuss earn-out later in the presentation, but these may not be an option where the seller will be a referral source post-closing. If want to do a management agreement, have to consider state fee-splitting laws.
  • In May 2009, the Department of Health and Human Services (HHS) and Department of Justice (DOJ) created the Health Care Fraud Prevention and Enforcement Action Team (HEAT). With its creation, the fight against Medicare fraud became a Cabinet-level priority. HEAT’s work is directed by HHS Secretary Kathleen Sebelius and Attorney General Eric Holder.OIG looking to alter the cost of doing business mindset of some corporate executives who run offending companies.Also want to alert physicians who receive kickbacks of their potential personal liability under exclusion and CMP authorities
  • Although providers have been operating under HIPAA for over a decade, the HITECH Amendments significantly increased HIPAA's reach and the potential liability for Business Associates.Before HITECH, business associates had only a contractual obligation to comply with the HIPAA Privacy and Security Rules, through a business associate agreement with a covered entity. Now, all business associates have a statutory obligation to comply with both HIPAA and HITECH. For the first time, business associates are subject to statutory penalties for a failure to comply with HIPAA’s Privacy, Security, or Breach Notification Rules.Massachusetts Provider Settles HIPAA Case for $1.5 Million – September 17, 2012Alaska DHSS Settles HIPAA Security Case for $1,700,000 – June 26, 2012HHS Settles Case with Phoenix Cardiac Surgery for Lack of HIPAA Safeguards --April 13, 2012HHS settles HIPAA case with BCBST for $1.5 million --March 13, 2012
  • In my practice I have seen an significant increase in CPOM issues. This is driven by the industry consolidation discussed earlier and PPACA driven changes in health care landscape.Physician practice acquisitions, urgent care clinics, Corporate entities need to carefully consider state CPOM restrictions before entering into transactions and if they proceed have to structure the deal to comply with CPOM.The corporate practice of medicine doctrine provides that lay corporations have no professional rights, privileges, or powers and therefore may not engage in the practice of medicine directly or indirectly by employing licensed professionals
  • Can consider friendly physician structure or other affiliates short of acquisition that can achieve business goals.Even arrangements that are not acquisitions can run afoul of state CPOM laws – e.g. management arrangements may run afoul of state CPOM laws if certain functions are delegated to the manager.Some states have strict fee-splitting laws that prohibit physicians from sharing fees with non-professionals – e.g., Illinois, New York, In such states, management fees may not be based on a percentage of revenuesNew York’s fee-splitting prohibition provides that a physician’s license may be revoked, suspended or annulled for professional misconduct if the physician requests, receives, participates in, or profits from “the division, transference, assignment, rebate, splitting or refunding of a fee” or “a commission, discount or gratuity” in connection with “providing professional care or services.” New York State Education Law § 6531
  • The seller indemnifies the buyer for losses caused by any breach of the representations, warranties or covenants. Seller may agree to place a portion of the purchase price in an escrow account for a period of time to secure payment on the indemnification. If there are no claims against the escrow the full amount is ultimately paid to the sellers; if claims are made, all or a portion of the escrow will be paid to the buyer and any balance paid to the seller.There is no consensus on what is “fair and reasonable” or “market” for escrows. How much should be placed in escrow? Depends on relative bargaining power. Seller may get higher total price by agreeing to indemnification holdback. Recent surveys estimate that 10% is reasonable.
  • What is an Earnout? - Typically, a portion of the purchase price is contingent on the future financial performance of the target business. Buyer pays the agreed earnout amount, if at all, in the years subsequent to the sale upon satisfaction of the Contingency. Payment is contingent on a future event, such as exceeding a specified gross revenue, net income, or EBIDTA.Contingent purchase price, or an “earnout” is an increasingly popular technique in private, middle market M&A transactions. An earnout is a valuable device for permitting a buyer and seller to reach agreement on a sale when the parties cannot agree on price.According to the Houlihan Lokey 2011 Purchase Agreement Study, summarizing 2002-2010 transactions in which Houlihan Lokey acted as investment banker:In 2002 - 2010 18% of transactions included an earnoutFrom 2009 – 2010 21% of transactions included an earnoutThe median earnout as a percentage of price was 9% in 2009 and 2010Earn out can help where Buyer wants the seller to stay active in and focused on the business after closing; Less risk for buyer; buyer can avoid overpaying for the target; Earnout as an incentive to retain and motivate key personnel of the target after closing.
  • Healthcare Transactions and Compliance

    1. 1. Presenting a live 90-minute webinar with interactive Q&AHealthcare Transactions and Compliancewith State and Federal Laws and RegulationsStructuring Transactions, Overcoming Regulatory Challenges,Determining FMV, and Performing Due DiligenceTHURSDAY, DECEMBER 20, 20121pm Eastern | 12pm Central | 11am Mountain | 10am Pacific Today’s faculty features: Theresa C. Carnegie, Member, Mintz Levin Cohn Ferris Glovsky & Popeo, Washington, D.C. Curtis H. Bernstein, CPA/ABV, ASA, CVA, MBA, Managing Director, Altegra Health, DenverThe audio portion of the conference may be accessed via the telephone or by using your computersspeakers. Please refer to the instructions emailed to registrants for additional information. If youhave any questions, please contact Customer Service at 1-800-926-7926 ext. 10.
    2. 2. Sound QualityIf you are listening via your computer speakers, please note that the quality ofyour sound will vary depending on the speed and quality of your internetconnection.If the sound quality is not satisfactory and you are listening via your computerspeakers, you may listen via the phone: dial 1-866-370-2805 and enter your PINwhen prompted. Otherwise, please send us a chat or immediately so we can address the problem.If you dialed in and have any difficulties during the call, press *0 for assistance.Viewing QualityTo maximize your screen, press the F11 key on your keyboard. To exit full screen,press the F11 key again.
    3. 3. FOR LIVE EVENT ONLYFor CLE purposes, please let us know how many people are listening at yourlocation by completing each of the following steps:• In the chat box, type (1) your company name and (2) the number of attendees at your location• Click the word balloon button to send
    4. 4. Healthcare Transactions andCompliance with State andFederal Laws and RegulationsTheresa C. Carnegie – Member, Mintz Levin202.661.8710TCCarnegie@mintz.comCurtis Bernstein, CPA/ABV, ASA, CVA, Altegra
    5. 5. Todays Discussion1. Health Care Transactions Trends2. Federal and State Regulatory Challenges3. Effective Due Diligence4. Valuation Considerations5. Strategies to Minimize Regulatory Risks6. Hypotheticals 5
    6. 6. Health Care Transactions Trends 6
    7. 7. Health Care Transactions – Trends• Unprecedented levels of change in the health care industry. – Patient Protection and Affordable Care Act (ACA) – Care Delivery Reform – Payment Reform – Increased Enforcement• These changes bring challenges and opportunities. – Some providers struggle with the intensive human and capital requirements and are motivated to sell or affiliate. – Other providers are more advanced and better positioned to compete and look to expand their footprint and improve scale. 7
    8. 8. Health Care Transactions – Trends• Past few years have been very active for the health care M&A market and strategic collaborations and affiliations. – In 2011, 980 health care mergers and acquisitions worth $227.4 billion. – In first 2 quarters of 2012, 500 health care deals recorded worth $95.2 billion.• Health Care Segment Trends – Hospital/Health System Consolidation – Physician Practice Acquisitions – Expansion of Health Insurance Companies into Health Care Services – Increase in ASC and Urgent Care Center Acquisition 8
    9. 9. Federal and State Regulatory Challenges 9
    10. 10. Navigating the Regulatory Challenges of Health Care Transactions• Health Care is a Highly Regulated Industry –Businesses in the health care industry are regulated by a wide array of federal and state laws enforced by various specialized regulatory agencies. –Violations of these laws can subject parties to health care transactions to onerous sanctions, including criminal penalties. 10
    11. 11. Federal and State Health Care Laws• Medicare/Medicaid Billing and • Stark Law and State Self-Referral Reimbursement Requirements Prohibitions• State Licensing and Certification • Federal and State False Claims Requirements (Entities and Acts Individuals) • HIPAA and State Privacy Laws• Industry Accreditation • State Corporate Practice of Requirements Medicine Prohibitions• Federal and State Anti-Kickback • State Fee Splitting Laws Laws • Antitrust Laws• Beneficiary Inducement Prohibitions • FDA Requirements 11
    12. 12. Federal and State Fraud Abuse Laws • Federal and State fraud and abuse laws are always a main focus of any regulatory review in health care transactions. • Includes – Anti-Kickback Laws, Stark Laws, FCA. • These laws can have a significant affect on deal structure. • Permissible Structures • Valuation Parameters • Payment Structure 12
    13. 13. Federal and State Fraud Abuse Laws • The financial implications of non-compliance with fraud and abuse laws can be significant. • Under ACA the reach of both the federal anti-kickback statute (AKS) and False Claims Act (FCA) has been expanded. – Lessened the governments burden on proving intent for AKS violations. – Linked AKS violations to violations of the FCA. – Provided for enhanced civil and criminal penalties for violations. 13
    14. 14. Federal and State Fraud and Abuse Laws• This expansion is combined with an overall trend toward increased government enforcement.• Under the HEAT Task Force health care fraud enforcement is a "cabinet-level" priority.• OIG increasingly focused on pursuing responsible individuals for exclusion and CMPs.• Penalty of exclusion from participation in federal health care programs can be a death sentence for a health care company. 14
    15. 15. HIPAA – Privacy and Security Laws• Under the HITECH Amendments to HIPAA, business associates are directly subject to HIPAA privacy and security requirements.• Business associates are subject to statutory penalties for a failure to comply with HIPAA’s Privacy, Security, or Breach Notification Rules.• Increased OCR Enforcement – Massachusetts Provider Settles HIPAA Case for $1.5M (Sept. 2012) – Alaska DHHS Settles HIPAA Security Case for $1.7M (June 2012) – Phoenix Cardiac Surgery Settles Case of $100K for Lack of HIPAA Safeguards (April 2012) – BCBST Settles HIPAA Case for $1.5M (March 2012) 15
    16. 16. Corporate Practice of Medicine Restrictions• Prohibition - Many states have strict “corporate practice of medicine” prohibitions that limit the extent to which a lay entity can control physicians and/or share medical practice revenues with physicians.• Exceptions – Although restrictions and exceptions vary by state, many states have exceptions for: • Professional corporations • Not-for-Profit Hospitals • HMOs • Teaching Hospitals• Penalties – If a lay entity is found to be practicing medicine through a corporate form, the corporation could be liable for the unlicensed practice of medicine and subject to criminal and civil penalties. 16
    17. 17. Corporate Practice of Medicine Restrictions• If the state has a corporate practice of medicine prohibition alternative deal and operating structures must be considered.• Where alternative structures involve Management Agreements, parties must consider state fee-splitting laws. –Some states have strict fee-splitting laws that prohibit physicians from sharing fees with non-professionals – e.g., Illinois, New York. –In such states, management fees may not be based on a percentage of revenues. 17
    18. 18. Effective Due Diligence 18
    19. 19. What is Due Diligence?• It is the process of obtaining and reviewing information about a company and using that information in the context of a specific transaction.• Due to the multi-layered regulatory environment, targeted, thorough, and thoughtful diligence is necessary in all health care transactions. 19
    20. 20. Why is Due Diligence Conducted?• Evaluate overall transaction, value, and purchase price• Identify risk areas• Identify issues that must be addressed in the Purchase Agreement• Ensure proper disclosures by Seller• Understand Seller’s operations• Evaluate financing and structure of transaction• Plan for post-closing integration 20
    21. 21. Common Areas of Focus for Health CareRegulatory Due Diligence• Contractual Arrangements• Corporate Books and Records• Licenses/Permits• Compliance Program• Government Correspondence and Investigations• Litigation (pending/threatened)• HIPAA Compliance• Billing and Coding• Marketing Materials 21
    22. 22. When reviewing these common areas, consider…• Contractual Arrangements – Does the arrangement potentially implicate the AKS or Stark Law? – Is it structured to comply with a safe harbor and/or exception? – Are the services provided legitimate? – FMV payments? – Is the arrangement used to improperly move money from a regulated entity to an unregulated entity? – Are the management services and fees set up to comply with corporate practice of medicine prohibitions? – Does the compensation structure improperly incentivize increased services or increased coding? 22
    23. 23. When reviewing these common areas, consider…• Corporate Books and Records –Does the structure comply with the corporate practice of medicine? –Is money transferred between affiliated entities in a proper way?• Licenses/Permits –Does the seller have all of the required approvals? –Do employees have all required licenses? –What governmental filings are necessary as a result of the transaction? 23
    24. 24. When reviewing these common areas, consider…• Compliance Program –Is the seller an entity that is required to have a Medicare compliant compliance program? –Does the program comply with CMS guidance and Federal Sentencing Guidelines? –Is it effective and updated regularly? –Does the seller regularly screen employees and contractors against the OIG exclusion list? –Is there a compliance hotline? What issues have been reported? –Who receives annual training? 24
    25. 25. When reviewing these common areas, consider…• Government Correspondence and Investigations –How is the sellers relationship with the government? –Are there any pending investigations or audit findings? –Has the seller received any warning letters?• Litigation –Health care fraud and abuse related litigation? –Any recent departures from the company? –Does the company conduct exit-interviews? 25
    26. 26. When reviewing these common areas, consider…• HIPAA Compliance –Has the seller implemented proper safeguards and security systems along with comprehensive HIPAA policies, procedures, and training? –Regulators will assume lack of documentation equates to a lack of compliance. –Are there existing breaches or complaints that will create post- closing liability? –Are IT security procedures adequate? • Consider post-closing costs of implementing new or upgrading existing systems. 26
    27. 27. When reviewing these common areas, consider…• Billing and Coding –May require outside consultant review. –Are billing and coding procedures in compliance with applicable law?• Marketing Materials –Are the Medicare Marketing Guidelines applicable to the seller? If so, has the seller complied with them? –Does the seller adequately train and supervise its sales force? –Are the sellers materials truthful and accurate? State consumer protection laws reach much further than the federal AKS and state kickback laws – has the Seller complied with them? 27
    28. 28. Outcome of Due Diligence Review• Based on the due diligence review, be prepared to adjust the transaction structure, documents, and price –Representations and Warranties –Indemnification/Holdback/Escrow –Disclosure Schedules –Conditions Precedent to Closing –Adjustments to Purchase Price –Legal Opinion 28
    29. 29. How do the due diligence findings affect the valueof the transaction/venture?• Has the Seller conducted business in a manner that may create risk under health laws (or other laws)?• Will a self-disclosure need to be made? If so, how much money may need to be re-paid?• Are the Sellers financial projections based on its past faulty billing procedures?• Are the financial projections based on relationships and arrangements that violate the AKS or Stark Law?• Are the Sellers facilities about to have their licenses revoked?• Will the Sellers payor contracts be terminated as a result of the transaction? 29
    30. 30. Valuation Considerations 30
    31. 31. Importance of Fair Market Value - Legal Perspective • That a transaction is valued appropriately and consistent with fair market value is important from both a financial and legal perspective. • In the health care industry, an arrangement (i.e., service agreements, leases, acquisitions) that is not priced to be consistent with fair market value can raise significant red flags under fraud and abuse laws and is unable to fall within an AKS safe harbor or a Stark Law exception. • Fair Market Value is not just an issue of the price of the transaction, it often impacts every arrangement for health related services that is reviewed in due diligence. 31
    32. 32. Importance of Fair Market Value - Legal Perspective• Although legal counsel is generally not in a position to determine FMV, it should be on the look out for problematic compensation structures or unsubstantiated valuations.• In Advisory Opinion 10-16, the OIG questioned the Requestors method for establishing fair market value.• The OIG noted that it is precluded from opining on fair market value, but stated that it must "evaluate whether the method used to determine that a fee represents fair market value appears reliable." 32
    33. 33. Fair Market Value vs. Investment Value• Cannot account for what a specific buyer brings to the table, only what the most likely hypothetical buyers could operationally adjust. –Example #1: Hospital proposes to purchase a 51% interest in a physician-owned ASC. Within the hospital, physicians employed by the hospital perform 1,500 cases per year that could be performed in an ASC setting. –Example #2: Private equity group proposes to purchase 10 diagnostic imaging centers from radiology group. Private equity group owns 25 other centers in the regional area and has 15% higher managed care reimbursement than the radiology group. 33
    34. 34. Billing and Coding Assessments• As part of the valuation process, valuators should perform a review of the sellers coding when applicable. –Volumes are compared to Medicare or other benchmarks • What is the distribution of patient visit codes? • What is the use of ancillary services as a percent of total services? –When reviewing MA or MA-PD Plans – • Has the Plan been using appropriate documentation to support its risk adjusted scores? • What are the RADV audit results for the Plan? • Will documentation practices need to change? 34
    35. 35. Adjusting Historical Financial Statements• Removal of Non-Recurring Expenses –Implementation of EMR • Consideration of meaningful use payments• Additional Expenses to Account for Growth –Space and staff needed to support growth 35
    36. 36. Projections• When performing an income approach, most valuation practitioners will prepare a projection (generally 5 years). –Example: Physician practice owns a sleep lab and proposes to sell the lab to the local hospital. The sleep lab has two beds. Practice currently performs 650 sleep studies of which 200 require CPAP. Growth Rate 5.0% 5.0% 5.0% 5.0% 5.0% CPT code Historical Year 1 Year 2 Year 3 Year 4 Year 5 Capacity Total 650 683 717 753 791 831 730 95811 200 210 220 231 243 255 95805 450 473 497 522 548 576 36
    37. 37. Terminal Value• At the end of the projection period, the valuator will develop an amount projected into perpetuity (generally the point where the company matures). –Example #1: Hospital proposes to purchase 20 physician cardiology group. Five of the physicians are 55 or older. As part of the negotiations, physician propose to reduce compensation by 15% to drive more value to the purchase price. –Example #2: Rehabilitation hospital opened in March 2012 with brand new equipment and furniture. As part of the valuation, the valuator projects capital expenditure for the next five years of $25,000 per year. 37
    38. 38. Assets Purchased and Liabilities Assumed• The valuator MUST know the terms of the transaction and tie back to the terms prior to the execution of the deal. –Example #1: Hospital proposes to purchase a physician practice. As part of the deal, the parties negotiate whether the hospital will assume the practices debt. The valuator determines that assets purchased equate to $1 million. The practice has $200,000 in debt, which the hospital assumes upon execution of the transaction. Effectively, the hospital has paid $1.2 million in consideration. –Example #2: Hospital purchases fixed assets from practice. Practice’s debt is subject to a lien on the fixed assets. 38
    39. 39. Assets Purchased and Liabilities Assumed• Is value transferred to the buyer upon sale? –Example #3: Hospital purchases physician practice. Hospital proposes to purchase certain tangible and intangible assets. In addition, physicians will earn higher compensation post transaction than earned when they owned the practice. 39
    40. 40. Market Approach• Understanding the comparable transactions is critical to the application of the market approach. –Personal service businesses should generally not be valued based on a revenue multiple when the owners of the business remain employees –Application of an earnings before interest, taxes, depreciation, and amortization (EBITDA) multiple or any other “market” defined multiple is only meaningful if the factors considered by the market are considered when applying the multiple. • Example #1: Surgery Centers • Example #2: Independent Physician Associations (IPAs)
    41. 41. Strategies to Minimize Regulatory Risks 41
    42. 42. Transaction Structure• Asset versus Stock – In an asset transaction, the Buyer can limit the assumed liabilities. Although certain liabilities may follow the assets even if not expressly assumed: • Tort Liabilities • Tax Liabilities • Environmental Liabilities – In stock transaction all liabilities are included (known and unknown, contingent or otherwise). • Accordingly, due diligence, representations and warranties, and indemnification protections are critical. 42
    43. 43. Purchase Price Allocation• Appropriate allocation of value to assets and liabilities is critical –If a purchaser buys intellectual property, non-competes, etc. and does not record the value of those assets on its financial statements, the purchaser will likely have a difficult time defending against any breach for improper use of technology or competition.
    44. 44. Representations and Warranties• Address Regulatory Compliance in Reps & Warranties – Non-compliance can impose significant successor liability and potentially large penalty assessments for fraud and abuse violations. – Typical Health Care Representations & Warranties • Licenses and Permits • Legal Proceedings • Compliance with Laws • Payment Programs • HIPAA – Other Considerations – Definitions, Material Contracts, Absence of Certain Events, No Undisclosed Liabilities 44
    45. 45. Holdbacks, Escrows and Earn-Outs• Buyers can use holdbacks, escrows and earn-outs (where permitted) to address regulatory risks.• Typically tied to performance, revenue, or compliance benchmarks.• Holdbacks and Escrows –Portion of purchase price held back or placed in an escrow account for a period of time to secure indemnification obligations or to address regulatory non-compliance. –Mitigates risk for Buyer. –Recent surveys estimate that 10% is reasonable – but depends on non-compliance the escrow/holdback is intended to address. 45
    46. 46. Holdbacks, Escrows and Earn-Outs• Earn-Out –Portion of the purchase price is contingent on the future financial performance of the target business. –Payment is contingent on a future event, such as exceeding a specified gross revenue, net income, or EBIDTA. –Buyer pays the agreed earnout amount, if at all, in the years subsequent to the sale upon satisfaction of the contingency. –Must ensure that earn-out structure is permissible under applicable fraud and abuse laws. 46
    47. 47. Survival and Indemnification• Survival Periods for Reps and Warranties –Create "classes" of reps and warranties. –"Standard" versus "Fundamental" • Health care representations and warranties as "Fundamental"• Caps and Baskets –Limit and apply to only certain reps and warranties. –Exclude Fundamental reps and warranties.• Sandbagging –Protection against recovery due to constructive knowledge. 47
    48. 48. Hypotheticals 48
    49. 49. Billing Practices• Hospital is looking to acquire a chain of urgent care clinics. Hospital determines through due diligence that the Seller has been incorrectly billing federal and private payors for a specific service.• Seller also discloses pre- and post-payment audit reviews by CMS and private payors with respect to the billing practices.• What steps can the Hospital take to address these regulatory risks? 49
    50. 50. Corporate Practice of Medicine/Fraud and Abuse• Private equity group is interested in acquiring large anesthesiology group in North Carolina. The anesthesiology group provides anesthesia services on an exclusive basis to several outpatient surgery/endoscopy centers owned and operated by physician-owned entities.• The anesthesiology group pays the centers a fee for management services including pre-operative nursing assessments, space for physicians/personnel, records, etc. and assistance with transfers of billing documentation.• What issues should the private equity group consider in connection with the potential acquisition? 50
    51. 51. Fraud and Abuse• Outstanding MA Plan is looking to buy Standard MA Plan. During due diligence, Outstanding MA Plan learns that: –Standard MA Plan has engaged Codes R Us to perform coding reviews of beneficiaries medical records. Codes R Us is paid $50 per chart reviewed and $25 for each additional code found that will increase the Plan’s revenue. –Standard MA Plan offers senior citizens in the area free transportation , free classes, and gift cards. –Standard MA Plan has arrangements with physicians that are undocumented and/or provide for extremely high compensation amounts.• Issues? What should Outstanding MA Plan do? 51
    52. 52. Questions? 52
    53. 53. Contact Information:Theresa C. CarnegieDirect Phone: 202-661-8710Email: TCCarnegie@mintz.comCurtis BernsteinDirect Phone: 720-240-4440Cell Phone: 561-901-5309Email:
    54. 54. To ask a question from your touchtone phone, press *#.To exit the queue, press *#.You may also use the Chat function to ask questions, or email questions tohealthlaw@straffordpub.comCLE CODE: TLWHBR
    55. 55. After you complete a briefsurvey of this program,well send you a free $5Starbucks Gift Card.Look for our Thank Youemail (which you shouldreceive shortly) for detailsand the survey link!
    56. 56. Please join us for our next legal conference, “Clinical Trial Agreements: Balancingthe Interests of Sponsors and Healthcare Providers - Drafting Indemnification, IPRights, Confidentiality and Other Key Provisions,” scheduled on Tuesday,January 8, 2013, starting at 1pm EDT.Strafford Publications,